Article Information
History
- November 15, 2021.
Article Versions
- You are currently viewing Version 1 of this article (November 15, 2021 - 17:37).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Feyza Yilmaz1,9,
- Umamaheswaran Gurusamy2,9,
- Trenell J. Mosley3,
- Yulia Mostovoy2,
- Tamim H. Shaikh4,
- Michael E. Zwick5,
- Pui-Yan Kwok2,6,
- Charles Lee1,7 and
- Jennifer G. Mulle8,*
- 1The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA
- 2Cardiovascular Research Institute and Institute for Human Genetics, UCSF School of Medicine, San Francisco, CA, USA
- 3Graduate Program in Genetics and Molecular Biology, Laney Graduate School, Emory University, 201 Dowman Drive, Atlanta, GA, 30322, USA
- 4Department of Pediatrics, Section of Genetics and Metabolism, University of Colorado School of Medicine, Aurora, CO, USA
- 5Department of Genetics, School of Arts and Sciences, Rutgers University, New Brunswick, NJ, USA
- 6Department of Dermatology, UCSF School of Medicine, San Francisco, CA, USA
- 7Precision Medicine Center, The First Affiliated Hospital of Xi’an Jiaotong University, 277 West Yanta Road, Xi’an 710061, Shaanxi, People’s Republic of China
- 8Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers Biomedical and Health Sciences, Rutgers University, New Brunswick, NJ, USA
- ↵*Corresponding author: jm2618{at}cabm.rutgers.edu
↵9 These authors contributed equally to this work
Posted November 15, 2021.
Multi-modal investigation of the schizophrenia-associated 3q29 genomic interval reveals global genetic diversity with unique haplotypes and segments that increase the risk for non-allelic homologous recombination NAHR
